Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

Biopsy devices market analysis 2036: explore cancer diagnostics trends, device forecasts, intervention volumes, pricing analysis, reimbursement insights, and competitive market dynamics.

Why Does the Biopsy Devices Market Matter?

Biopsy devices play a critical role in diagnosing and examining tissue samples, supporting the detection and assessment of cancer and other medical conditions. Increasing global cancer incidence is a primary driver of market demand, while biopsies are also used in the management and diagnosis of non-cancerous conditions, including chronic kidney disease (CKD), liver cirrhosis and organ transplantations.

The market covers a range of devices, including biopsy guns, vacuum-assisted needle devices, biopsy forceps, biopsy punches and biopsy needles. Understanding demand across these product segments requires visibility into intervention volumes, device usage, average selling prices, market values and competitive positioning.

GlobalData’s Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 provides a comprehensive assessment of the market across 39 countries. The interactive market model combines quantitative forecasts with qualitative insights, country-specific healthcare system analysis, reimbursement policies and medtech regulatory intelligence to support strategic planning and commercial decision-making.

Key Insights in the Biopsy Devices Market

• Market size and forecasts: Analyse annualised biopsy devices market revenue by segment, with historical data and forecasts covering 2015–2036.
• Device segmentation: Examine biopsy guns, vacuum-assisted needle devices, biopsy forceps, biopsy punches and biopsy needles.
• Cancer-driven demand: Assess the impact of cancer incidence on biopsy procedures through epidemiology-based market modelling.
• Non-cancer indications: Understand biopsy demand associated with chronic kidney disease, liver cirrhosis and organ transplantations, including kidney and liver transplants.
• Intervention and volume analysis: Track total interventions, device units and product usage across global, regional and country markets.
• Pricing and revenue intelligence: Evaluate average selling prices, market values and revenue trends by segment.
• Competitive landscape: Assess leading companies, market shares and competitive positioning, including company share and rank analysis where available.
• Market access and regulation: Understand country-specific reimbursement policies, healthcare systems and medtech regulatory environments.
• Country-level market intelligence: Compare market developments across 39 countries through sourced, colour-coded market models and analyst commentary.

Scope

What Will You Learn from This Biopsy Devices Market Report?

• Market size and growth outlook: What is the current and forecast value of the biopsy devices market across key segments and countries through 2036?
• Product segment performance: How are biopsy guns, vacuum-assisted needle devices, biopsy forceps, biopsy punches and biopsy needles performing?
• Disease-driven demand: How do cancer incidence and selected non-cancer indications influence biopsy intervention volumes?
• Intervention and device volumes: How many interventions and device units are recorded across the markets covered?
• Pricing dynamics: How are average selling prices and market values evolving across product segments?
• Competitive positioning: Which companies are active in the biopsy devices market, and how do market shares and company rankings compare?
• Reimbursement environment: What reimbursement policies influence access to biopsy devices across individual countries?
• Regulatory requirements: How do country-specific medtech regulations and healthcare systems shape the market?
• Market opportunities: Which segments and geographies may offer opportunities for investment, partnerships and commercial expansion?

Who Should Buy This Biopsy Devices Market Report?

This report is designed for organisations seeking detailed market intelligence to support commercial, investment and strategic decisions, including:

• CMO and senior commercial executives: Understand market trends, segment performance and competitive dynamics to support strategic planning and investment decisions.
• Sourcing and procurement executives: Assess the supplier landscape and competitive positioning to inform supplier selection and management.
• Private equity investors: Evaluate market size, growth prospects, company positioning and potential investment targets.
• Medical device manufacturers: Track product segment performance, intervention volumes, pricing and competitive developments.
• Business development and licensing teams: Identify relevant companies and market opportunities to support in-licensing, out-licensing and partnership strategies.
• Sales and marketing teams: Understand market leaders, company shares and country-level opportunities to refine commercial strategies.
  

  

How Companies Use This Biopsy Devices Market Analysis

Organisations can use this market model to:

• Develop licensing strategies: Review the competitive landscape and key companies to inform in-licensing and out-licensing decisions.
• Build market strategies: Understand the trends, disease indications and product segments shaping biopsy device demand.
• Identify revenue opportunities: Evaluate market size, intervention volumes, product usage and pricing across segments and countries.
• Strengthen sales and marketing plans: Assess company market shares and competitive positioning to identify priority segments and geographies.
• Evaluate emerging competitors: Identify companies with relevant product portfolios and develop strategies to respond to competitive threats.
• Track historical and forecast sales: Monitor biopsy device market performance across global and country-specific markets from 2015 to 2036.
• Prioritise investments and partnerships: Identify market categories and segments that may offer opportunities for consolidation, investment and strategic collaboration.
• Assess market access requirements: Use country-specific reimbursement and regulatory insights to support commercial planning.

Reasons to Buy

Benchmark the Global Biopsy Devices Landscape

Gain a detailed view of the biopsy devices market through analysis of:

• Market revenue by product segment from 2015–2036.
• Biopsy guns, vacuum-assisted needle devices, biopsy forceps, biopsy punches and biopsy needles.
• Total interventions, device units and product usage.
• Average selling prices and market values by segment.
• Epidemiology-based indications, including cancer, CKD, liver cirrhosis and kidney and liver transplantations.
• Company market shares, rankings and competitive dynamics.
• Global, regional and country-specific market trends.
• Country-level healthcare systems and reimbursement policies.
• Medtech regulatory landscapes across 39 countries.
• SWOT analysis and qualitative analyst commentary.

The model covers the United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Companies covered include: Becton Dickinson and Co, Devicor Medical Products Inc, Hologic Inc, Wilson-Cook Medical Inc, Boston Scientific Corp, Medtronic Plc, CONMED Corp, Olympus Corp, Argon Medical Devices Inc, Henry Schein Inc, Coloplast A/S, Merit Medical Systems Inc, Integra LifeSciences Holdings Corp, Teleflex Inc, Acuderm Inc, United States Endoscopy Group Inc and others.

Built on GlobalData Intelligence

GlobalData combines demand- and supply-side primary research with quantitative market modelling and qualitative analyst insights to provide a detailed view of the biopsy devices market.

The market model draws on key opinion leaders, government procedure databases, hospital purchasing databases and proprietary online databases. These sources support the assessment of market trends, intervention volumes, device usage, average selling prices and competitive developments.

The interactive Excel deliverable provides sourced, colour-coded market models across 39 countries, supported by analyst commentary, healthcare system assessments, reimbursement information and medtech regulatory analysis.

Act Now to Identify Opportunities in the Biopsy Devices Market

Understand where demand is developing, how product segments are performing and which companies are shaping the competitive landscape. Use GlobalData’s Biopsy Devices Market Analysis to track market performance from 2015 to 2036, evaluate country-specific opportunities and support informed decisions across investment, licensing, procurement and commercial strategy.